Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | CN | 01 Nov 2024 | |
Breast Cancer | Phase 1 | CN | 14 Oct 2022 | |
Colorectal Cancer | Phase 1 | CN | 14 Oct 2022 | |
Lung Cancer | Phase 1 | CN | 14 Oct 2022 | |
Ovarian Cancer | Phase 1 | CN | 14 Oct 2022 | |
Pancreatic Cancer | Phase 1 | CN | 14 Oct 2022 | |
Thyroid Cancer | Phase 1 | CN | 14 Oct 2022 | |
Uterine Cervical Cancer | Phase 1 | CN | 14 Oct 2022 | |
Vulvar Neoplasms | Phase 1 | CN | 14 Oct 2022 |
Not Applicable | - | 60 | 纳米炭组 | ufdayqwele(xzyunhtgpk) = zdlonykeqh coxduxuwuc (awvghccxms ) View more | - | 25 Sep 2021 | |
纳米炭混悬注射液 (对照组) | ufdayqwele(xzyunhtgpk) = jteqehwwzt coxduxuwuc (awvghccxms ) View more | ||||||
Not Applicable | - | 60 | 纳米炭组 | cbojvljaxx(tdycjxhslw) = mqpmyhdblc gmesfkuzaa (mqdyxbzcny ) View more | - | 19 Sep 2020 | |
纳米炭混悬注射液 (对照组) | cbojvljaxx(tdycjxhslw) = wihjojpggv gmesfkuzaa (mqdyxbzcny ) View more |